SDC, Materials and Methods

Additional Themes
Subthemes that were identified within the data, but do not relate to a measureable quality attribute of the individual transplant programs.
Quality Issues due to Funding
Certain subthemes that emerged from the data identified problems at higher levels that are largely dependent on funding at the provincial or national level. These are issues that would be inherent at all institutions, or could not be easily addressed at the program level. Monitoring these areas would not provide a quality attributes that would distinguish the programs, and they are not actionable items at the local level.
Resource Use: Care providers thought that the number of patients and procedures performed at a center should be collected in part because these hard numbers are often requested by funders. The number of transplants by type of kidney and the number of transplant opportunities lost by type of transplant were identified as important sources of information about a program. Some care providers spoke about monitoring the total cost of the patient care, including the cost of dialysis, the transplant surgery, allied health resources, and increased costs attributed to prolonged patient and donor evaluation. The allotted resources of a program were discussed including the number of nursing and physician hours allotted and the number of beds available, which could impact the quality of care depending on the size of the program.
"We can also see how many patients have potential living organ donors, living organ donation rates so there are those kind of things that we can measure." (Doctor 22) "So the funders usually measure hard outcomes like numbers of transplants. They measure death on the waitlist or withdrawal from the waitlist because of becoming too ill to receive a transplant." (Doctor 33) "But I mean I don't know from an upper bureaucrat point of view again linking in to how much is, you know, you can measure the cost of dialysis but how much extra cost is there for this person? In terms of, you know, if they're on social assistance, if there's Access-a-Bus getting them to and from dialysis, you know, what other costs? Is there a way for this to happen that we can link somebody's care provider or their patient number to try and get some real, real numbers on the cost of care. You know, it's medication access, it's, you know, if they're living independently with their own income?" (Doctor 26) "And I think the structure nursing hours, physician hours, number of hospital beds, it is measured within the greater hospital system of which transplant is a part of it." (Doctor 32) "I mean we I think like, would like to be able to benchmark how many coordinators we have for the number of patient's we're assessing. The access to allied healthcare I think might be a thing that could be benchmarked that would tell, you know, it doesn't tell you how you're doing but it, it might indicate whether you are right sized." (Doctor 48)
-Number of transplants, by donor type -Number of referrals -Number on the waitlist -Proportion of patients preemptively transplanted -Proportion of living vs. deceased donor transplants -Cost of transplant -Total healthcare costs due to prolonged donor evaluation -Cost of dialysis -Total cost of all care for patient -Number of nursing hours allotted -Number of physician hours allotted -Number of hospital beds for transplant patients Limited Resources: The idea that transplant programs operate with limited resources was woven throughout the patient interviews. Many patients suggested that the funding for transplant programs is insufficient, affecting many aspects of care, including the amount of time allotted to patients, housekeeping duties, and access to allied health professionals. Care providers also felt that the funding for transplant programs is insufficient, and that enhancing resources could improve the quality of care. To enhance resources, some care providers suggested re-investing the money saved by getting people off dialysis into transplant care, or to decant stable posttransplant patients back to the care of community nephrologists. The physical space of some transplant programs has been affected by limited resources; some care providers feel that their program needs more space in order to provide better quality of care for their patients, while another care provider suggested that their clinic requires updated facilities. Care providers also touched on the discrepancies of resources between centers and between provinces. Programs may differ in the availability of specialized procedures, such as DCD, their ability to accept high risk patients, or the availability of specialists and diagnostic procedures; and these differences in resources can lead to unequal access to treatment across Canada. -Is there a provincial strategy to help patients pay for medications? -What are the incidental costs associated with treatment that patients must pay?
Geographic barriers: Care providers spoke about geography as a major barrier affecting the accessibility of services at both the individual and systemic levels. This was felt to contribute to differences in access to care between and within provinces. Some care providers suggested that access to care was more challenging for individuals who live outside major urban centers, with added costs for travel and accommodations. 
Quality Issues due to Organ Procurement
Although the shortage of organs directly affects whether a patient can receive a transplant, deceased donor organ procurement and the process of evaluating living donors are out of control of the transplant programs, and therefore cannot be used to measure quality of the transplant program.
Availability of organs: The scarce supply of kidneys was identified as the biggest barrier to receiving a transplant, and the long wait for deceased donor kidneys was a source of frustration for patients. Care providers also spoke to the 'gap between supply and demand of organs' presenting the largest barrier for receiving a transplant, and the need to make sure that this limited resource is allocated in a fair and equitable manner. Care providers extended the notion of availability of organs to include whether or not patients had access to a living donor, and whether the transplant programs promoted preemptive transplants. -Average time on wait list -Wait time from referral to transplant -Is the allocation policy appropriate for producing the best outcomes? Table S1 . Extra Quotations Access to Treatment Standardized transplant referral: "So I don't think waitlist, access to the waitlist is uniform in Canada. Even though we use the system based on wait time, some people are referring earlier than others and that's just not in kidneys it's in all organs. And so standardizing the referral to the waitlist and refreshing that regularly as a country I think is important" (Ad #35) "I think the first thing that happens is before they even get to a transplant center, it's a little bit of a crap shoot as to whether or not they end up in a dialysis center that champions transplantation or a dialysis center that's kind of neutral. I would never go so far as to accuse any dialysis center of being negative about it but I think neutrality frankly is negative because transplant is the best treatment of choice for the vast majority. ... So I think part of it is their first barrier they're not even aware of it's a barrier of geography."(Dr #32) "So we find that funding, provincial funding is an issue I think for access to transplantation. It's still the case in our region I think mostly across Canada that dialysis is remunerated better than taking care of transplant recipients. So there is an incentive for referring nephrologists, a financial incentive to refer late rather. And I think that's a mindset that needs to be changed. It's well known that transplantation is the best form of renal replacement therapy and also the most cost-effective for governments. But it is still not funded that way at least not in our region. So I think that's a barrier that patients get referred late from other provinces because, because of financial incentives or lack there of but also perhaps workload and other physician-related issues that I can't really comment on." (Dr #47) Lengthy transplant evaluation process: "Sometimes coordination of care can be a bit of a challenge for us if we're working patients up for transplant. So kids that are coming from out of town, kids that coming from a distance, we sometimes try to do all of their outpatient diagnostic testing, work-ups, consults, within a couple of days. So the family can kind of plan to come into the city, have a couple of days of testing and work-up done and then not have to make multiple trips back in and out. But sometimes in order, in order to be able to do, to facilitate multiple, multiple appointments in a day it means that you have to wait and, and things take longer than they should." (Ad #36) "We document when we've received the, the referral to our program and then once the patient is listed so we have those time points. So we're just starting to understand and, and work towards using the new Trillium wait times that are, that we're to be documenting. So the wait times 1A and 1B." (Ad #36) "So for deceased, recipients who don't have living donors, the only access metric we could measure is the time of referral to listing. But we can't do referral to transplant because the time to transplant is largely outside of the transplant center's hands." (Dr #32) "And then after referral what's the process like? Are people having to wait enormous lengths of time for assessments? What's the redundancy in the system? How much repetitiveness is there in regard to reexaminations, retesting, all that kind of stuff? And at the end of the day how quickly do people actually get transplanted following a referral?" (Dr # 25) "What length of time do they sit in every stage of evaluation? What are the barriers to timely evaluation?" (Dr #32)
Lengthy living donor evaluation
"So how long does it take you to get this evaluation done the cross match results, the surgical review and the medical review by center? And if that's an efficient, really important piece. Up until we started being able to show this information to programs like I said earlier it could take so long we'd lose the donors." (Ad #35) "Right now they're just declared as lost and not why and so we've got no way of understanding them more deeply. And living donor transplants lost so the for example, a recipient accepts a deceased donation and transplant instead of waiting for what might be a better case which is a living donor. We're not tracking those types of transactions." (Ad #35) Accessibility of Services Alternative access options: "I think there are some centers that have made use of Telemedicine technology to try and be sensitive to patients that may be coming from great distances." (Ad #27) "I think, you know, I think our patients actually get pretty good posttransplant care. Our nurses see them 3 times/week for the first 3 weeks and we see them regularly. They've got a pretty direct line into the nurses if they've got complaints." (Dr #37) "It's quite a ways to go but like I'm, sometime I wonder like right now we go every 4 months for blood work. I was just like you're probably in there maybe 10 minutes like I'm pretty sure now most of this is being done in our hospital in [small town] which is half an hour away. So, you know, it comes to mind why couldn't they do it there kind of thing and forward it to [major city]?" (Pt #13) Flexible appointment availability: "So I think that part of the physical location could be improved and potentially also sort of access to some resources on weekends. So right now our medical daycare and phlebotomy services are only open Monday through Friday and not on holidays. So kids that need, again thinking of the posttransplant kids, if they need care on a weekend they have to go to the inpatient area, yeah which isn't ideal." (Ad #36) "But if, if we want to find a back-up plan I think we need to identify those patients in the system where when they don't show to any clinic they have to be identified in that system as a potential transplant candidate and that system has to give them a priority by rescheduling them and by sending a {kind of like} auto reminder to the transplant coordinator. To say like "Patient didn't show so why didn't show?" Is it because they forgot? Is it because of they, they are sick? So I think that's that will help significantly." (Dr #28) Appropriate Amount of Follow-up "In addition, most transplant centers in the, in the country with I mean there are exceptions, tend to be the ones providing most of the care as it relates to the transplant. And, you know, one wonders whether or not a lot more of that care could be, could be pushed back to not just the primary care providers but perhaps the nephrologists in the community as well." (Ad #27) "I think access to healthcare professionals though, you know, patients who see a physician on a regular basis versus those that don't see a physician on a regular basis may have better access to transplant." (Dr #31) "And the testing that needs to be done I think can be sometimes onerous on patients. And where it's done and how frequently it's done remains a bit of an issue. And I think again we don't really have good understanding as to how often certain tests need to be done or repeated on the waitlist. There are some standards for things such as HLA testing but major, major question marks as to how often someone needs cardiovascular testing on the waitlist."(Ad #27) "And we have reduced I know in [major city] they do everybody there every 3 months or they used to be. We have people that come once/year, you know, a lot of them that are stable out more than 5 years so that it does reduce the burden of, of travel for patients. And, you know, I don't know what the impact of that is, but I mean they get monitored, blood work monitored more frequently. I mean, you know, a couple of, every couple of months. So we've, you know, we've, we've adapted so that they, they live fairly normal lives whether that's good or bad or not I don't know." (Dr #21) Barriers for accessing care: N/A Program Resources Comprehensive multidisciplinary care: "Social work the easiest and most surface response is that Saskatchewan's pretty geographically challenged. So just getting patients to appointments posttransplant just to monitor their kidney, keep them healthy follow up is very difficult. So on the surface there's that. There's funding that they work with. But our social workers in a deeper level a lot of these patients will struggle once they've received an organ in particular an organ quite often from a deceased person is something that they don't understand the gravity of until they've it's actually happened to them. And our social workers are invaluable in that." (Ad #49) "We have the setup in our program, to on each visit see nurse, physician, pharmacist, nutritionist, exercise physiology when needed and social work when needed." (Dr #33) "And there was the diet and, and the thing is they had all kinds of resources there that were available to me. I, you can speak to a dietitian, you know, like or a social worker. There was just the help was there for me." (Pt 10) "I think in terms of, you know, transplant nurses posttransplant, pharmacy support, social work support that kind of thing those are all available to us and are very important in terms of quality of care. I think it's, you know, that that multidisciplinary approach is really important." (Ad #41) Knowledgeable staff: "It's concentrated expertise that understands transplant….. So sometimes not having that expertise or, you know, that level of seniority there to understand the transplant process so in terms of, you know, what's being told to the patient. Recognizing that, you know, missing an immuno suppressant drug is an important thing. Recognizing and measuring urine output in the first few days is important or doing weights on a patient. But, you know, depending on the flux of your ward this can vary substantially." (Dr #24) "How could we improve the quality of care that we give? Well we could have more nurse coordinators available. A better patient to nurse ratio that would be very helpful and just as important is that we find that the pharmacy, pharmacist to patient ratio should be lower as well." (Ad #43) "So for example, our program is growing and growing and growing all the time, but there is, we're always behind with the kind of our manpower. So there is more pressure on the current staff to do their thing let alone providing the same quality of care or meet our current standards when we have excessive number of patients under our care." (Ad #50) "Certainly there are the appropriate number of staff to manage the patient load that's one thing…. Yeah, what we find in some centers is that they're so understaffed they're barely keeping up with the current state never mind preparing for what's coming. So they're always out of step so it's a bit of that as well if that helps." (Ad #35) "We've been concentrating more on the patients themselves, but appropriate staff and nurse coordinators to run the center that would probably have a large impact on quality of care. So maybe looking at ratios of patients to coordinators because when you have a reasonable ratio then you're gonna be able to provide that education. I guess that would be one thing." (Dr #31) Peer support groups: N/A Educational resources: "We have done, we have done some I mean we've done education days where we've done, where we've done some, you know, pretransplant, pre and posttransplant education days. Family education days where we're covering many of those, you know, sort of highlights of education sort of, you know, topics that are relative to the families at varying points in their transplant continuum." (Ad #36) "Hmm, you know, honestly I would have to say that because I had a really, really good nephrologist and she gave me lots of reading material before I ever had to have the transplant. And I think for me it was really helpful because it helped me to know what I was getting into and what I could do to make the whole process much easier." (Pt #12) "Yeah the education I found very valuable." (Pt #18) "But some programs and our program in particular has a patient forum group. And patients are invited to partake in it with our allied health staff. And basically what we do on a regular basis is we have patients come up with ideas for topics that they want to hear and discuss and we put on patient engaged, patient directed in terms of what they want to hear, symposiums with professionals that speak. We do this a couple or 3 times/year for our patients." (Ad #27) Patient navigators/advocates: "I don't think that we necessarily fully understand how difficult it is for patients to ask their families and their community for assistance in asking for living donors." (Ad #41) "I don't think that we've optimized living donation in Canada. I think the likelihood if you're, if you're white [laugh] and you're well educated with a reasonable medium income is you have a much better chance of ever having a living donor transplant than if you're not Caucasian, and if you are a first generation or second generation Canadian, if you haven't finished high school and if you don't live in a major urban center. The likelihood of getting a living donor transplant goes down dramatically. So we have major healthcare inequity in terms of access to transplant that way." (Dr #32) Communications of Information Taking time to answer questions: N/A Clear communication about treatment: "I mean I think, I think it's important to like I think it should all be open. Like there shouldn't be any surprises so when it comes to testing and the process of, of what has to happen that that people are aware of that so that they're prepared for that." (Pt #17) "Right now patients know that they, they have visits. They have to do some testing. They have there's misunderstanding as to when they're actually on the waitlist. And I think while they're waiting there's a bit of a gap as to knowing what it really means to be on the waitlist. And, and I think some way of, of patients having a better understanding and better information about the entire process of, of waiting for a kidney would be, would be a, would be a good thing."(Ad #27) "It's the most major barrier for sure is information. So you need to get reliable information in the hands of the referring providers and the patients and their families. All so that they understand as thoroughly as possible about what their transplant options are so that they can make their decisions about it. That's the biggest barrier." (Dr #38) "Keeping them, having ensuring that they have a good understanding of the process that they're undertaking. A lot of maybe the referral process requires them to navigate through a certain system. That can be challenging for them."(Ad #29) "So I think the biggest thing is waiting time pretransplant, sorry navigation through the pretransplant process is the place that I hear the most frustration from patients and families be it preemptive or otherwise. And so from and that's where I go to all my knowledge stuff like they don't know where they are, they don't know what's happening. They don't understand why it doesn't, why it takes so long so I think some kind of, you know, visual aids that say "This is how long you should expect things to take." Like I mean I don't think we do a good job of, of that." (Dr #23) "So quality of care with the pretransplant encounter is accessibility and knowledge of the patient about what's gonna happen and clarity around expectations etc." (Dr #23) "I mean I've encountered patients who were shocked to discover after their transplant, for example that they are no longer considered disabled and would actually have to get a job. We don't do a very good job of, of handling that sort of, that sort of thing." (Doctor. #44) "And I think quality of care for a patient would be understanding who to speak, who to reach out to when they need to whether it's the transplant clinic or their primary care physician or other healthcare professionals."(Ad #27) "A successful kidney transplant would be that #1 the recipient was prepared preoperatively so they understood all of the implications of having a transplant and were going into it well educated and open-mindedly." (Ad #41) "Hmm well, you know first of all I think we have to have patients who are knowledgeable about what they are about to embark on so that they know the benefits and the risks of either staying on a renal replacement modality or commencing a replacement modality or getting a transplant. And I think that it's very important to provide information that both patient and support systems understand so that the process is totally transparent and totally informed all along the way. I think that once the decision is made to receive a transplant it's very important for patients to know what that process involves in terms of testing, length of time on potential waiting lists and those kinds of things. And also, you know, what life is going to be like after the transplant."(Ad #34) Communication tailored to patients: "It always amazing me when we tell people before the transplant that they're gonna be gone in 5 days, that when on day 4 when you come and tell them that they're going, they're like all surprised. So something's wrong with the way we communicate." (Dr #23) "Equally I've had patients tell me the same thing about they didn't realize they were on hold or why. And so, you know, not so not, not assuming it's not been said to them, but they didn't understand it." (Ad #35) "Quite often the patients they don't understand what it is that they're getting into [laugh] when they go into to go for a transplant or to be considered for transplantation. So that all starts in the beginning with them education and knowing how to communicate to your patients, and then them staying listed." ( Health Outcomes Freedom from dialysis: "I think from a practical perspective we like to see good graft outcomes so good patient and graft survival posttransplant." (Dr #48) "I think a successful kidney transplant would be one that occurs in a timely fashion for that specific patient to minimize significant waiting. That successfully gets them off dialysis with minimal risks of immuno suppression and overall long-term graft function, stability of long-term graft function." (Dr #31) "Oh I think overall simple things and that's survival at different time points posttransplant. But I suppose it's also, also you want to make sure that they have good organ function posttransplant as well. So those would be my 2 sort of major things and then obviously patient survival. So graft survival, patient survival, and then organ function at defined time points." (Dr #38) "I'm kind of lucky in that sense that it kicked in right away and did its work so that was a beautiful match. I got to compliment to all the, all the lab technicians there for matching me up with a beautiful kidney" (Pt #3) "Yeah I mean I do think it's still pretty simple. I think you have to look at patient graft survival as based on the kind of patients that you're transplanting, you know, adjusting for their comorbidities. You have to look at I think readmission rates and, you know, and preventable causes of graft loss. I don't think it's anything more magical than that." (Dr #21) "Very important to ensure that there is follow-up happening. To graft status which is, is the graft functioning? Has it failed? Is it meaning is it no longer sustaining life or is there some intervention required such as dialysis or relisting? What's the cause of the failure? So it's graft status, rejection the date of rejection the type of rejection. How that rejection is being treated? A lot of information on dialysis whether there's restart of dialysis, the date, the type. Continual who's the, who's providing the dialysis? And follow up on whether there are any symptoms of diabetes. Is it a new onset, date of new onset, how the blood sugar is being controlled? And quite a number of labs values that would be followed continually." (Ad #43) Long term health: "And also I would think, you know, that a successful kidney transplantation is also a kidney transplantation where we are able to prevent and decrease long-term complications…. And in the long terms all the complications, long-term complications cardiovascular and neoplastic infectious and so on." (Dr #22) "So I guess getting the transplant and, you know, having a good short length of stay without too many complications. And having a kidney transplant in a, in a short period of time from listing to transplant. Feeling engaged in the planning and decision making around your care. Having no incidents or safety issues happen during your transplant."(Ad #29) "A successful kidney transplant is one that restores a quality of life and health to a person that is substantially different than what they had before in a positive way with a minimum of immuno suppression and a maximum mobility and return to things that they weren't otherwise able to do." (Dr #23) "The good outcome then would also be somebody whose course is smooth. They don't have any perioperative or postoperative complications, are able to return home fairly quickly; are able to probably go back to work if they were doing that before their referral for transplant; are taking their medications without any complications or side effects and who basically are just sailing through the system." (Dr #25) "So a successful transplant is a patient who's done well with their kidney and has all their other healthcare, healthcare issues minimized [laugh] as much as possible" (Ad #27) "So you could look at posttransplant outcomes in terms of, you know, safety in terms of rejection. In terms of, you know, any mortality or different risk factors posttransplant. And then bring them back into the pretransplant. So if we know something, you know, is showing up repeatedly post then develop protocols pretransplant to ensure those kinds of things are looked at." (Ad #41) "Readmission rates we mentioned I think those would probably be the big ones. I think rejection rate might be important but there's so many other variables that impact rejection rates so it would be hard to, hard to say that that's not safe care." (Dr #31) "I guess one could look at a number of things aside from the usual graft outcomes and, and patient, patient survival outcomes and graft outcomes which are very large brushes. I think one could look at the rates of rehospitalizations, the rates of infections, the rates of cardiovascular events, the rates of malignancies and a whole bunch of other things, which clearly are people have looked at in the past. But not always easy to do and, of course, would have to be very, very carefully controlled for, depending on the patient population that one's looking at." (Ad #27) "Then once the transplant is in place certainly careful follow up and attention to detail and making sure that people are well educated, capable of self-management. Interacting closely with the transplant care team and then, you know, freedom from complications. So not getting into trouble with infections, malignancies, rejection episodes, or really short transplant survival rates and that kind of thing." (Dr #25) Short term health: "So some of the things that we're monitoring as I said the length of stay, readmission rates, so hand hygiene, C-diff rate, pressure ulcers, medication errors, patient falls etc. So there's some key metrics that we as a hospital have looked at. We've also initiated what we call HACs (Hospital Acquired Conditions) which entails some of those but also surgical site infection, central line infections are added to that. So those are some key things. I think we've mentioned some of the others like the survival rate and patient satisfaction." (Ad #29) "We can look at days in hospital and the reasons for days in hospital beyond a certain standard. Because the best place for transplant patients to be is at home after their transplant. So we need to understand what's keeping people in hospital and looking at not only length of stay but the reasons for excessive length of stay." (Dr #32)
Fear of infections:
"We should be reporting on so to a surveillance system like public health agency any infection or infectious diseases that are from any recovered organ that could affect other donors or other recipients. So that's sort of the public health agency system for, for organs is right now being explored." (Ad #35) "You'd be looking at serious infections like, like symptomatic CMV disease." (Dr #38) Patient Satisfaction Returning to normal life: "Hmm I find that my, well I mean compared to when I was sick with kidney failure I mean the quality of life is a hundred times better. You know I'm like energy again. I can do things again and not fatigued and I don't feel sick, right." (Pt #17) "Hmm the, the quality of life I'm still alive. I'm not on dialysis. I'm enjoying life more than I did at, at first before the transplant." (Pt #19) "And at the end of the day for patients I think that process should be as minimally disruptive as possible but by definition it is disruptive. And also should lead to an improved, a substantial or a tangible improvement not only in longevity but also the quality of their lives across various domains, physical, mental, emotional and so forth." (Dr #24) "I would think the most important outcome is actually that they live again healthy and well like however you really want to define it. Quality of life or in fact, that's probably the most important that they live well that they live independently that they can have high function that they're not too medicalized that they can enjoy the things in life that they'd like to enjoy. All those things are probably the most important things for patients I would say. Of course, survival's also important but I wouldn't say that was the number 1." (Dr #40) "So if they're not, you know, regaining all of their energy, their ability to sleep and interact with their families and go back to work and resume exercise and everything like that they consider that they've not met the goal of a successful transplantation." (Dr #42) "So if they're not, you know, regaining all of their energy, their ability to sleep and interact with their families and go back to work and resume exercise and everything like that they consider that they've not met the goal of a successful transplantation." (Dr #33) "A successful kidney transplant is where the recipient is able to resume or maintain a near normal lifestyle. So whether if they're young go on and have a family, get back to work, travel, that's sort of success to me." (Dr #37) "So I think patient knowledge of their condition. How aware they are of what they need to do etc. would be a measure of quality because it would mean that they understood and got everything. And the other thing is a measure of symptom burden and quality of life or depression skills. I think that those would be things that we should measure in terms of quality metrics." (Dr #23) "So some of the things that we have just been looking at and kind of following some of the work that's happened with our oncology program where they use a DART tool. So things like symptom management again how, how are they feeling after their transplant? What activities have they been able to resume? So more I think around not only the outcome measures that we look at from a scientific approach but more around how the patient's feeling and functioning in their day-to-day activities?...It incorporates multiple tools to assess patients as to how they're, how they're doing so how are they feeling physically and also mentally and emotionally? It involves part of it would be the ESAS tool and then they've "And we need to shift the entire culture of quality in our healthcare system to one of system level improvement. And we do that by celebrating errors. And I don't mean we say "Let's go commit errors." I'm saying when an issue comes up blame is taken off the table. We never waste an incident or a medical error and never waste that learning opportunity. Celebrate the people who are brave enough to bring it forward and discuss it and change the entire culture of blame and shame." (Dr #32) "Most of the time it comes down to being aware of what kind of adverse events could occur and which ones are potentially avoidable with by appropriate care being provided? Some of that relates to medication safety. Having appropriate systems where the patient is fully educated around their medications as timely access to them has somebody tracking whether they're actually filling them. And monitoring of drug levels and so on would be part of that." (Dr #25) "I mean we've safety for the preop period we've spent a lot of time trying to detect some clinical diseases that might cause the patient to run into trouble when they get their transplant. So we look hard to try and identify patients who have increased cardiovascular risk and we may even recommend that patients undergo, you know, for example I have a patient right now who was found to have coronary artery disease during his assessment work-up and he's currently awaiting a bypass graft. And the assumption is that if he had his bypass graft before transplantation we'll have reduced is cardiovascular risk at the time of organ transplantation. And that's probably true. And so that's a way of mitigating risk I guess is to, to identify and deal with problems that may crop up and cause an issue during the transplant process itself." (Dr #44) Patient health status on the wait list: N/A
